SS

Shobhanaben Savani

Active Director Director DIN 11969716
DIN 11969716 First appointment Sep 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Shobhanaben Savani

Shobhanaben Savani is a Director at Agriurja Biotech Private Limited (since 2026).

DIN 11969716
Primary Designation Director
First Appointment 29 Sep 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Agriurja Biotech Private Limited U35201GJ2026PTC184413
Director29 Sep 20262026Active

Directorship timeline

Open interactive timeline →
Agriurja Biotech Private Limited
Premium access

Shareholding and investment profile for Shobhanaben Savani

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shobhanaben Savani

Shobhanaben Savani currently holds 1 directorship: Agriurja Biotech Private Limited (Director, since 29 Sep 2026).

Shobhanaben Savani was first appointed on 29 Sep 2026 as Director at Agriurja Biotech Private Limited.

The current boards of Shobhanaben Savani's companies include Akashbhai Rashminbhai Savani (Agriurja Biotech Private Limited), Bipinbhai Jivrajbhai Vaghasiya (Agriurja Biotech Private Limited), Hardikkumar Pravinbhai Savani (Agriurja Biotech Private Limited), Hiteshbhai Khodabhai Savani (Agriurja Biotech Private Limited), Pareshbhai Khodabhai Savani (Agriurja Biotech Private Limited), Rashminbhai Kanubhai Savani (Agriurja Biotech Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available